SIRIO(300791)
Search documents
仙乐健康(300791) - 信息披露管理制度(2025年12月)
2025-12-22 07:58
仙乐健康科技股份有限公司 信息披露管理制度 仙乐健康科技股份有限公司 信息披露管理制度 第一章 总则 第一条 为规范仙乐健康科技股份有限公司(以下简称"公司")及其他信 息披露义务人的信息披露行为,加强信息披露事务管理,提高公司信息披露管理 水平和信息披露质量,保护投资者的合法权益,依据《中华人民共和国公司法》 (以下简称"《公司法》")、《中华人民共和国证券法》(以下简称"《证券 法》")、中国证券监督管理委员会(以下简称"中国证监会")发布的《上市 公司信息披露管理办法》《深圳证券交易所创业板股票上市规则》(以下简称"《上 市规则》")、《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》等有关法律、法规、规章、规范性文件和证券交易所业务规则、 《仙乐健康科技股份有限公司章程》的规定,结合公司实际,制定本制度。 第二条 本制度所称"信息"是指对公司发行的股票或其他证券及其衍生品 种的价格或者投资决策可能产生重大影响的信息或事项以及证券监管部门要求 披露的信息或事项。 本制度所称"披露"是指公司或相关信息披露义务人按法律、行政法规、部 门规章、其他规范性文件、《上市规则》及证券交易所 ...
仙乐健康(300791) - 关于部分募集资金投资项目延期的公告
2025-12-22 07:58
| 证券代码:300791 | 证券简称:仙乐健康 | 公告编码:2025-105 | | --- | --- | --- | | 债券代码:123113 | 债券简称:仙乐转债 | | 仙乐健康科技股份有限公司 关于部分募集资金投资项目延期的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 仙乐健康科技股份有限公司(以下简称"公司")于 2025 年 12 月 19 日召 开第四届董事会第十六次会议,审议通过了《关于部分募集资金投资项目延期的 议案》,董事会同意公司将募集资金投资项目"数字信息化建设项目"的达到预 计可使用状态日期调整至 2026 年 12 月 31 日。现将相关情况公告如下: 一、募集资金的基本情况 经中国证券监督管理委员会《关于同意仙乐健康科技股份有限公司向不特定 对象发行可转换公司债券注册的批复》(证监许可[2021]927 号)同意注册,公 司向不特定对象发行可转换公司债券数量 10,248,929 张,募集资金总额为 102,489.29 万元,扣除发行费用 1,148.43 万元,实际募集资金净额为 101,340.86 万元 ...
仙乐健康(300791) - 关于修订公司部分规章制度的公告
2025-12-22 07:58
仙乐健康科技股份有限公司 关于修订公司部分规章制度的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 仙乐健康科技股份有限公司(以下简称"公司")于 2025 年 12 月 19 日召 开第四届董事会第十六次会议,审议通过了《关于修订公司部分规章制度的议案》, 现将详情公告如下: | 证券代码:300791 | 证券简称:仙乐健康 | 公告编码:2025-104 | | --- | --- | --- | | 债券代码:123113 | 债券简称:仙乐转债 | | 二、备查文件 1、仙乐健康科技股份有限公司第四届董事会第十六次会议决议; 1 2、仙乐健康科技股份有限公司第四届董事会薪酬与考核委员会第九次会议 决议。 特此公告。 一、概况 根据《上市公司治理准则(2025 年修订)》(以下简称"《治理准则》") 及其他相关规则最新要求,结合公司实际,对公司部分规章制度进行修订和完善。 具体如下: | 序号 | 规章制度名称 | | --- | --- | | 1 | 股东会议事规则 | | 2 | 信息披露管理制度 | | 3 | 董事、高级管理人员及其他核 ...
仙乐健康(300791) - 公司章程(2025年12月)
2025-12-22 07:58
仙乐健康科技股份有限公司 章 程 仙乐健康科技股份有限公司章程 目 录 | 第一章 | 总则 | 3 | | --- | --- | --- | | 第二章 | 经营宗旨和范围 | 4 | | 第三章 股 | 份 | 5 | | 第一节 | 股份发行 | 5 | | 第二节 | 股份增减和回购 | 6 | | 第四章 | 股东和股东会 | 8 | | 第一节 | 股东的一般规定 | 8 | | 第二节 | 控股股东和实际控制人 | 11 | | 第三节 | 股东会的一般规定 | 12 | | 第四节 | 股东会的召集 | 16 | | 第五节 | 股东会的提案与通知 | 18 | | 第六节 | 股东会的召开 | 19 | | 第七节 | 股东会的表决和决议 | 22 | | 第五章 | 董事和董事会 | 27 | | 第一节 | 董事的一般规定 | 27 | | 第二节 | 董事会 | 32 | | 第三节 | 独立董事 | 37 | | 第四节 | 董事会专门委员会 | 40 | | 第六章 | 高级管理人员 | 41 | | 第七章 | 财务会计制度、利润分配和审计 | 43 | | 第一节 | 财务会 ...
仙乐健康(300791) - 招商证券股份有限公司关于仙乐健康科技股份有限公司部分募集资金投资项目延期的核查意见
2025-12-22 07:58
招商证券股份有限公司 关于仙乐健康科技股份有限公司 招商证券股份有限公司(以下简称"招商证券"或"保荐机构")作为仙乐 健康科技股份有限公司(以下简称"仙乐健康"或"公司")向不特定对象发行 可转换公司债券的保荐机构及持续督导机构,根据《证券发行上市保荐业务管理 办法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律 监管指引第 2 号——创业板上市公司规范运作》及《上市公司募集资金监管规 则》等相关法律法规和规范性文件的要求,对仙乐健康部分募集资金投资项目延 期的事项进行了审慎核查,核查情况及核查意见如下: 一、募集资金基本情况 经中国证券监督管理委员会《关于同意仙乐健康科技股份有限公司向不特定 对象发行可转换公司债券注册的批复》(证监许可[2021]927 号)同意注册,公 司向不特定对象发行可转换公司债券数量 10,248,929 张,募集资金总额为 102,489.29 万元,扣除发行费用 1,148.43 万元,实际募集资金净额为 101,340.86 万元。上述募集资金到位情况已经华兴会计师事务所(特殊普通合伙)审验,并 出具"华兴验字[2021]21000020045 号"的《验 ...
仙乐健康(300791) - 第四届董事会第十六次会议决议公告
2025-12-22 07:58
| 证券代码:300791 | 证券简称:仙乐健康 公告编码:2025-102 | | --- | --- | | 债券代码:123113 | 债券简称:仙乐转债 | 1、审议通过了《关于变更公司注册资本及修订〈公司章程〉的议案》 经审议,董事会同意将公司总股本由 307,318,960 股变更为 307,634,663 股, 注册资本由 307,318,960 元变更为 307,634,663 元,同时,根据《上市公司治理准 则(2025 年修订)》及其他相关规则最新要求的规定,结合公司实际,对《公 1 司章程》进行完善和修订。董事会提请股东会授权公司董事长或董事长授权的相 关人员具体办理本次《公司章程》修订涉及的企业变更登记、章程备案手续并签 署相关文件,授权有效期限自股东会审议通过之日起至本次企业变更登记及章程 备案手续办理完毕之日止。 仙乐健康科技股份有限公司 第四届董事会第十六次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有 虚假记载、误导性陈述或重大遗漏。 一、 董事会会议召开情况 仙乐健康科技股份有限公司(以下简称"公司")第四届董事会第十六次会 议于 2025 年 ...
仙乐健康(300791) - 股东会议事规则(2025年12月)
2025-12-22 07:58
仙乐健康科技股份有限公司 股东会议事规则 仙乐健康科技股份有限公司 股东会议事规则 第一章 总则 第一条 为促使仙乐健康科技股份有限公司(下称"公司")股东会会议 的顺利进行,规范股东会的组织和行为,提高股东会议事效率,维护股东合法权 益,保证股东会能够依法行使职权及其程序和决议内容有效、合法,根据《中华 人民共和国公司法》(以下简称"《公司法》")《上市公司股东会规则》《仙 乐健康科技股份有限公司章程》(以下简称"公司章程")等有关规定,特制定 本规则。 第二条 股东会是公司的权力机构,依法行使下列职权: (十五)审议法律、行政法规、部门规章或者公司章程规定应当由股东会决定 的其他事项。 公司经股东会决议,或者经股东会授权由董事会决议,可以发行股票、可转 1 (一)选举和更换非由职工代表担任的董事,决定有关董事的报酬事项; (二)审议批准董事会的报告; (三)审议批准公司的利润分配方案和弥补亏损方案; (四)对公司增加或者减少注册资本作出决议; (五)对发行公司债券作出决议; (六)对公司合并、分立、解散、清算或者变更公司形式作出决议; (七)修改公司章程; (八)对公司聘用、解聘承办公司审计业务的会计师事 ...
保健品行业专题报告:新动向,新成长
East Money Securities· 2025-12-22 07:38
Investment Rating - The report maintains a "Strongly Outperform" rating for the health supplement industry [3] Core Insights - The health supplement market in China is expected to grow significantly, with a retail scale projected to reach 260.2 billion yuan by 2024, reflecting a CAGR of 6.3% from 2019 to 2024 [6][16] - The industry is characterized by a dual driving force from both mature markets and emerging consumer trends, with a notable shift towards younger demographics and new consumption patterns [22][40] - The contract manufacturing segment is anticipated to see increased concentration, benefiting from stable demand growth and the influx of new brands [2][8] Summary by Sections 1. Continuous Expansion of Health Supplements - The health supplement market is expanding, with the global market expected to reach 191.5 billion USD by 2024 [16] - The penetration rate of health supplements in China is significantly lower than in developed countries, indicating substantial growth potential [21][20] 2. Consumer Changes Driving Channel Transformation and Product Iteration - The primary sales channels for health supplements have shifted from direct sales and pharmacies to e-commerce, with e-commerce accounting for 48.02% of sales in 2023 [46] - The rise of live-streaming e-commerce has significantly contributed to the growth of the health supplement industry, with a penetration rate projected to reach 34.3% by 2024 [6][46] 3. Increased Concentration in the Contract Manufacturing Segment - The contract manufacturing segment is expected to benefit from the growing demand for health supplements, with major players like Xianle Health and Baihe Co. projected to capture significant market shares [2][7] - Brand owners are actively adapting to new trends, focusing on product innovation and channel diversification to capture market opportunities [8][7] 4. Investment Recommendations - The report suggests focusing on leading contract manufacturers with strong R&D capabilities and those that are well-positioned to benefit from emerging consumer trends [8] - Specific companies recommended for investment include Xianle Health and Baihe Co. in the contract manufacturing space, and H&H International Holdings and Tongrentang in the brand segment [8]
中国银河证券:新消费为食饮板块核心投资主线之一 未来重点看好大健康食品方向
Zhi Tong Cai Jing· 2025-12-17 06:41
Core Viewpoint - New consumption categories, represented by health food, are identified as a core investment theme for the food and beverage sector in 2025, with expectations for continuity into 2026 and beyond. The focus will be on health food as a key investment direction due to its rich SKU variety and long-tail structure, similar to the snack sector investment logic [1] Industry Overview - The health food market, including natural and nutritional health foods, has a combined market size of approximately 600 billion yuan. Since 2025, there have been profound changes in external demand and distribution channels, driven by a shift in consumer demographics from the elderly to younger groups and an expansion of consumption scenarios from disease prevention to personalized needs such as emotional relief and weight management. Additionally, the rise of interest e-commerce, cross-border e-commerce, and membership supermarkets has addressed issues of consumer trust and category recognition [1] Category Insights - The investment logic for health food is similar to that of the snack sector, focusing on selecting listed companies that are well-positioned in key categories. The "function-scenario-price" triangle is crucial for identifying potential best-selling products. Recommended categories include: - Oats: Market size of 10 billion yuan, low GI characteristics, and versatile usage in breakfast and snacks [2] - Corn: Market size of approximately 200 billion yuan, low GI, and broad acceptance as both a staple and snack [2] - Walnuts: Market size of 80 billion yuan, beneficial for heart and brain health, with a competitive price among tree nuts [2] - Black sesame: Beneficial for hair nourishment, priced around 1 yuan per bag, with applications in traditional and baking scenarios [2] - Sports health: Market size of approximately 6 billion yuan, expected to grow with the increasing number of fitness enthusiasts [2] - Gut health: Online market size estimated at 4 billion yuan, with probiotics accounting for over 75% [2] Key Companies - Companies that are strategically positioned in potential categories are expected to achieve rapid growth: - Ximai Food: Leading in the domestic cereal industry with a revenue CAGR of approximately 18% over the past three years [3] - October Rice Field: A new consumption brand with a revenue CAGR of about 17% over the past three years [3] - Wugu Mofang: Leading in walnut and sesame powder, recovering from a low point with a revenue CAGR of around 9% [3] - Xianle Health: A leading CDMO in China with a revenue CAGR of approximately 21% over the past three years [3] - Junyao Health: A pioneer in probiotic foods with a revenue CAGR of about 17% over the past three years [3]
新消费品类系列深度研究(一):大健康食品投资品类图谱
Yin He Zheng Quan· 2025-12-17 03:28
Investment Rating - The report maintains a "Recommended" rating for the food and beverage industry [1] Core Insights - The health food market is approximately 600 billion yuan, with significant growth potential driven by changing consumer demographics and preferences [3][5] - The report emphasizes the importance of new consumption trends, particularly in the health food sector, which is expected to continue its growth trajectory into 2026 and beyond [3] - Key product categories identified for growth include oats, corn, walnuts, and other health foods, which are expected to thrive due to their health benefits and consumer acceptance [3][5] Summary by Sections 1. Demand and Channel Transformation - The health food market is divided into natural health foods (over 300 billion yuan) and nutritional health foods (approximately 250 billion yuan) [5] - Consumer demand is shifting from older demographics to younger groups, with a focus on personalized health needs such as emotional relief and weight management [5][9] - New sales channels, including e-commerce and membership supermarkets, are enhancing consumer trust and product awareness [14][15] 2. Natural Health Foods - Key categories include oats, corn, nuts, and other health foods, which are expected to see significant growth due to their health benefits and consumer recognition [18][27] - Oats are projected to have a market size of 10.1 billion yuan in 2024, while corn is expected to reach 220.9 billion yuan [29][30] - Walnuts are anticipated to have a market size of 78.7 billion yuan in 2024, benefiting from increased consumer awareness of their health properties [36] 3. Nutritional Health Foods - The nutritional health food segment includes dietary supplements, weight management products, and sports nutrition [42] - The market for sports nutrition is projected to reach approximately 6.4 billion yuan in 2024, driven by the growing fitness trend [49] - Weight management products are expected to grow to around 16.9 billion yuan, supported by increasing consumer awareness of health and wellness [54] 4. Key Companies - Notable companies in the natural health food sector include West麦食品, 十月稻田, and 五谷磨坊, which are positioned for rapid growth due to their innovative products and market strategies [61] - In the nutritional health food sector, companies like 汤臣倍健 and 仙乐健康 are highlighted for their strong market presence and growth potential [61]